Related Experiment Video

Updated: Jun 19, 2026

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

Immediate relief of Mycoplasma pneumoniae encephalitis symptoms after intravenous immunoglobulin

Caroline Chambert-Loir1, Marie Ouachee, Kevin Collins

  • 1Service of Pediatric Neurology and Metabolic Diseases, Robert Debré Hospital, Paris France.

Pediatric Neurology
|October 13, 2009
PubMed

Insights

This case study highlights Mycoplasma pneumoniae encephalitis in a child, presenting with neurological symptoms. Intravenous gamma-globulin therapy rapidly resolved symptoms, suggesting its potential efficacy.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Neuroimmunology

Background:

  • Mycoplasma pneumoniae infections can lead to severe neurological complications, including acute encephalitis.
  • Standard antibiotic treatments may not always resolve these neurological sequelae.
  • Encephalitis presentation can be diverse, involving symptoms like tics, behavioral changes, and cerebellar dysfunction.

Observation:

  • A 12-year-old presented with acute orofacial tics, motor restlessness, compulsive behavior, and cerebellar symptoms.
  • Cerebrospinal fluid analysis revealed lymphocytic meningitis and strongly positive PCR for M. pneumoniae.
  • Antibody tests for M. pneumoniae in blood and CSF were negative.

Findings:

  • Intravenous gamma-globulin (IVIG) administration resulted in rapid and dramatic clinical improvement within 72 hours.
  • Symptoms, including neurological deficits, resolved completely after IVIG treatment.
  • This case highlights a positive response to IVIG in PCR-confirmed M. pneumoniae encephalitis.

Implications:

  • Intravenous gamma-globulin may be a valuable therapeutic option for Mycoplasma pneumoniae encephalitis.
  • Further investigation in larger patient cohorts is warranted to confirm the efficacy of IVIG in suspected cases.
  • Early consideration of IVIG in pediatric encephalitis with confirmed M. pneumoniae could improve patient outcomes.

More Related Videos

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...